Fig. 4
From: SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
a Kaplan–Meier survival curve comparing the disease-free survival of patients with mismatch repair protein deficient colon cancer of all stages stratified by SATB2/CDX2 expression. Patients with SATB2 and/or CDX2-negative tumors had reduced disease-free survival compared with patients with CDX2-positive/SATB2-positive tumors (p < 0.001). b Kaplan–Meier survival curve comparing the disease-free survival of patients with stage II or stage III mismatch repair protein deficient tumors stratified by SATB2/CDX2 expression. Patients with SATB2 and/or CDX2-negative tumors had reduced disease-free survival compared with patients with CDX2-positive/SATB2-positive tumors (p < 0.001)
